| A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) (NCT05263999) | Equillium | 2022-04-29 |
| Safety and Tolerability of FMT Capsules in Healthy Volunteers (NCT05352269) | Shenzhen Xbiome Biotech Co., Ltd. | 2022-04-21 |
| Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD (NCT04910152) | Hannah Choe, MD | 2022-04-19 |
| Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial (NCT05236062) | Dana-Farber Cancer Institute | 2022-04-14 |
| Infliximab Efficacy in Relation to Therapeutic Drug Monitoring and Serum TNFα Levels in Pediatric HSCT (NCT05825833) | IRCCS Burlo Garofolo | 2022-03-10 |
| Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation (NCT05149365) | The First Affiliated Hospital of Soochow University | 2021-12-22 |
| Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease (NCT05121142) | Children's Hospital Medical Center, Cincinnati | 2021-10-27 |
| HBOT in the Treatment and Prevention of aGVHD (NCT05078073) | Shandong Provincial Hospital | 2021-10-10 |
| Abatacept s.c. for aGVHD Prevention in Haplo-HCT (NCT04686929) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| MTX and Steroid for III-IV aGVHD Treatment (NCT04958538) | Peking University People's Hospital | 2021-04-21 |
| Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005) (NCT04095858) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2021-01-05 |
| ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients (NCT04006652) | Washington University School of Medicine | 2020-12-16 |
| Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT04539470) | Genentech, Inc. | 2020-11-19 |
| Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation (NCT03764228) | Peking University People's Hospital | 2020-07-01 |
| Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease (NCT04291261) | Universitätsklinikum Hamburg-Eppendorf | 2020-05-18 |
| FMT for Steroid Resistant Gut Acute GVHD (NCT04285424) | Affiliated Hospital to Academy of Military Medical Sciences | 2020-03-01 |
| Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects (NCT03721965) | Incyte Corporation | 2019-12-31 |
| RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT04014790) | Regimmune Corporation | 2019-11-25 |
| A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD (NCT03763318) | Biocon Limited | 2019-07-15 |
| The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant (NCT03805789) | CSL Behring | 2019-03-27 |
| Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease (NCT03491215) | Novartis Pharmaceuticals | 2019-02-21 |
| UCMSCs as Front-line Approach of Treatment for Patients With aGVHD (NCT03847844) | Cytopeutics Sdn. Bhd. | 2019-02-01 |
| A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease (NCT03605940) | Central Hospital, Nancy, France | 2018-10-01 |
| Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies (NCT03557749) | Masonic Cancer Center, University of Minnesota | 2018-09-21 |
| Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease (NCT03158896) | University of Kansas Medical Center | 2018-07-09 |
| Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (NCT03057054) | Children's Oncology Group | 2018-04-30 |
| Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects (NCT03497273) | Incyte Corporation | 2018-03-20 |
| An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) (NCT03339297) | Jazz Pharmaceuticals | 2018-02-21 |
| FMT in Gut aGVHD Treated (NCT03148743) | The First Affiliated Hospital of Soochow University | 2017-05-16 |
| Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections (NCT02805946) | Radboud University Medical Center | 2017-04-28 |
| Clinical Trial With MSC for Graft Versus Host Disease Treatment (NCT02687646) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2017-02-20 |
| Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies (NCT02743351) | Fate Therapeutics | 2016-12-20 |
| Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease (NCT02133924) | John Levine | 2016-08-01 |
| Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid Myopathy (NCT04521777) | M.D. Anderson Cancer Center | 2015-10-01 |
| Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract (NCT02425813) | Wake Forest University Health Sciences | 2015-10-01 |
| A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant (NCT02436460) | AbGenomics B.V Taiwan Branch | 2015-05-01 |
| Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease (NCT02611180) | Washington University School of Medicine | 2015-04-30 |
| Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation (NCT02659657) | Peking University People's Hospital | 2015-03-01 |
| BMT Autologous MSCs for GvHD (NCT02359929) | Emory University | 2015-01-01 |
| MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD (NCT02241018) | Nanfang Hospital, Southern Medical University | 2014-09-01 |
| Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation (NCT02044185) | Seoul St. Mary's Hospital | 2014-01-01 |
| Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) (NCT01903473) | University of Liege | 2013-07-01 |
| Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease (NCT01765634) | Nanfang Hospital, Southern Medical University | 2013-01-01 |
| PETCT for Diagnosing and Monitoring Acute GVHD (NCT01596192) | Rabin Medical Center | 2012-05-01 |
| Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (NCT01521039) | Ohio State University Comprehensive Cancer Center | 2012-02-20 |
| Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease (NCT01475162) | Medical College of Wisconsin | 2011-08-08 |
| Pharmacological Predictors of Successful Cyclosporine Acute GVHD Prophylaxis in Children Undergoing HSCT (NCT02175615) | Lee Dupuis | 2010-10-01 |
| Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD) (NCT01140984) | Hadassah Medical Organization | 2010-09-01 |
| Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease (NCT00640497) | Henogen | 2010-01-01 |
| Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (NCT00803010) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease (NCT00726375) | University of Michigan Rogel Cancer Center | 2008-05-01 |
| Markers of Inflammation in Hematopoietic Stem Cell Transplant (NCT00579397) | Ann & Robert H Lurie Children's Hospital of Chicago | 2007-04-01 |
| Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT01220297) | Stanford University | 2006-08-01 |
| Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease (NCT00282503) | Mallinckrodt | 2006-01-01 |
| Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD (NCT00032773) | Astex Pharmaceuticals, Inc. | 2002-01-30 |
| Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD (NCT00038792) | M.D. Anderson Cancer Center | 2000-10-01 |
| Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) (NCT03172455) | Impatients N.V. trading as myTomorrows | |